Intra-abdominal temperature distribution during consolidation hyperthermic intraperitoneal chemotherapy with carboplatin in the treatment of advanced stage ovarian carcinoma
- PMID: 25707816
- DOI: 10.3109/02656736.2015.1007399
Intra-abdominal temperature distribution during consolidation hyperthermic intraperitoneal chemotherapy with carboplatin in the treatment of advanced stage ovarian carcinoma
Abstract
Purpose: Hyperthermic intraperitoneal chemotherapy (HIPEC) involves the continuous heating and circulation of chemotherapy throughout the abdominal cavity in an attempt to enhance cytotoxicity. Despite the potential of this chemotherapy procedure, there are scant anatomical temperature distribution studies reporting on this therapeutic process.
Patients and methods: We prospectively evaluated the temperature of select anatomical (e.g. upper abdominal, mid-abdominal and supra-pubic) sites in 11 advanced stage ovarian cancer patients who were treated with consolidation HIPEC carboplatin (AUC 10). The temperature of the aforementioned anatomical regions and the inflow/outflow tubing was measured at baseline and at 15-min intervals until the procedure's completion.
Results: The lowest observed mean composite temperature was 41.1 °C at the supra-pubic site whereas the highest temperature was 42.6 °C, in association with the inflow/outflow tubing. During the various time intervals we also ascertained that the lowest composite temperature was 40.9 °C at baseline (i.e. time 0), whereas the highest value (41.8 °C) occurred at multiple time periods (e.g., 15, 45 and 60 min).
Conclusion: The HIPEC temperature variation amongst the various abdominal sites and time intervals was minimal. We also discerned that uniform temperature distribution throughout the abdominal cavity was facilitated when the abdomen was both maximally distended with fluid and a high flow rate was maintained.
Keywords: Carboplatin; HIPEC; intra-abdominal heat distribution; ovarian cancer.
Similar articles
-
Consolidation hyperthermic intraperitoneal chemotherapy for the treatment of advanced stage ovarian carcinoma: a 3 year experience.Cancer Chemother Pharmacol. 2017 Aug;80(2):405-410. doi: 10.1007/s00280-017-3376-8. Epub 2017 Jul 1. Cancer Chemother Pharmacol. 2017. PMID: 28669065
-
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial.Gynecol Oncol. 2011 Aug;122(2):215-20. doi: 10.1016/j.ygyno.2011.05.004. Epub 2011 Jun 12. Gynecol Oncol. 2011. PMID: 21665254 Clinical Trial.
-
Abdomino-pelvic hyperthermia and intraperitoneal carboplatin in epithelial ovarian cancer: feasibility, tolerance and pharmacology.Int J Radiat Oncol Biol Phys. 1996 Jul 15;35(5):993-1001. doi: 10.1016/0360-3016(96)00092-2. Int J Radiat Oncol Biol Phys. 1996. PMID: 8751408
-
The role of cytoreductive surgery and HIPEC in epithelial ovarian cancer.J BUON. 2015 May;20 Suppl 1:S12-28. J BUON. 2015. PMID: 26051328 Review.
-
New paradigms in the surgical and adjuvant treatment of ovarian cancer.Minerva Ginecol. 2014 Apr;66(2):179-92. Minerva Ginecol. 2014. PMID: 24848076 Review.
Cited by
-
Safety, feasibility, and application of intraperitoneal gas-based hyperthermia beyond 43°C in the treatment of peritoneal metastasis: An in-vivo pilot study.Front Oncol. 2022 Oct 11;12:953920. doi: 10.3389/fonc.2022.953920. eCollection 2022. Front Oncol. 2022. PMID: 36303827 Free PMC article.
-
New experimental model for single liver lobe hyperthermia in small animals using non-directional microwaves.PLoS One. 2017 Sep 21;12(9):e0184810. doi: 10.1371/journal.pone.0184810. eCollection 2017. PLoS One. 2017. PMID: 28934251 Free PMC article.
-
In-vivo thermodynamic exploration of gas-based intraperitoneal hyperthermia.Front Oncol. 2022 Aug 29;12:925724. doi: 10.3389/fonc.2022.925724. eCollection 2022. Front Oncol. 2022. PMID: 36106116 Free PMC article.
-
A precise temperature control during hyperthermic intraperitoneal chemotherapy promises an early return of bowel function.Cancer Biol Ther. 2020 Aug 2;21(8):726-732. doi: 10.1080/15384047.2020.1775444. Epub 2020 Jun 17. Cancer Biol Ther. 2020. PMID: 32644887 Free PMC article.
-
Evaluating the concept of gas‑based intraperitoneal hyperthermia beyond 43˚C in the treatment of peritoneal metastasis: A pilot study.Exp Ther Med. 2022 Nov 8;24(6):752. doi: 10.3892/etm.2022.11687. eCollection 2022 Dec. Exp Ther Med. 2022. PMID: 36561969 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical